Here, we report a comparison and analysis of in vivo efficacy and gene expression for tumor-localized catalases in two different compartments, either injected and retained in the tumor (extracellular) or over-expressed by tumor cells (intracellular) (Figs. 1 and 2). This evidence concerns the gene CAT and neoplasm.